Precision medicine in the context of Alzheimer's Disease and dementia involves tailoring treatment and prevention strategies to individual genetic, environmental, and lifestyle factors. Unlike traditional approaches, which often offer generalized treatments, precision medicine seeks to identify specific biomarkers and genetic profiles that contribute to the onset and progression of these conditions. By leveraging advanced technologies like genomics and neuroimaging, researchers aim to develop personalized therapies that could slow disease progression or even prevent it altogether. This approach holds promise in improving diagnostic accuracy, predicting disease risk more precisely, and optimizing therapeutic interventions based on individual patient characteristics. Ultimately, the goal is to transform Alzheimer's and dementia care from reactive to proactive, offering targeted treatments that are more effective and potentially life-changing for patients and their families.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States